Influenza vaccine effectiveness in older adults: study methods, transparency and impacts on public health

• Joshua Nealon,
• Tor Biering-Sørensen,
• Pascal Crépey,
• Rebecca Harris,
• Tom Schaberg,
• Ayman Chit

Affiliations

Joshua Nealon

Sanofi Vaccines, Lyon, France; Corresponding author. Joshua Nealon, 14 Espace Henry Vallee, 69007 Lyon, France.

Tor Biering-Sørensen

Department of Cardiology, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Steno Diabetes Center, Copenhagen, Denmark

Pascal Crépey

Ecole des hautes études en santé publique (EHESP), Université de Rennes, CNRS, IEP Rennes, France

Rebecca Harris

Sanofi Vaccines, Lyon, France

Tom Schaberg

Formerly Centre for Pneumology, Rotenburg, Germany

Ayman Chit

Sanofi Vaccines, Lyon, France; Leslie Dean Faculty of Pharmacy, University of Toronto, Toronto, Canada